alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group

Term ID

CHEBI:16565

Synonyms

5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl
alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl group
alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-R
alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc
Neu5Ac-(alpha2,3)-Gal-(beta1,3)-GalNAc-(alpha1)
Neu5Acalpha2-3Galbeta1-3GalNAcalpha-

Definition

An N-acetyl-D-galactosaminyl group in which a sialic acid residue (Neu5Ac) is linked α(2→3) to a galactose residue which is in turn linked β(1→3) to the D-GalNAc group which has α-configuration at its anomeric centre.

References

kegg.compound:C04901
kegg.glycan:G00026
pubmed:11530204
pubmed:17988798

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group

Phenotype where environments contain alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group

Phenotype modified by environments containing alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group

Phenotype affecting alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group

Human Disease Model